@nablabio Profile picture

Nabla Bio

@nablabio

Antibodies designed, not discovered. Learn more at https://t.co/eqRIJxp7JJ

Similar User
Asimov photo

@AsimovBio

Dyno Therapeutics, Inc. photo

@Dyno_Tx

Judy Savitskaya photo

@heyjudka

Generate:Biomedicines photo

@generate_biomed

Diego del Alamo photo

@DdelAlamo

Relation photo

@RelationRx

Vincere Bio photo

@VincereBio

Boston Protein Design and Modeling Club photo

@ProteinBoston

Tony Kulesa photo

@kulesatony

Christopher Voigt photo

@Geneticdesigner

Nabiha Saklayen photo

@nabsicle

Mohammed AlQuraishi photo

@MoAlQuraishi

Insilico Medicine photo

@InSilicoMeds

Ochre Bio photo

@OchreBio

Altos Labs photo

@altos_labs

Nabla Bio Reposted

I’m speaking today at @PEGSboston, 5:10 pm, Eng Antibodies. Talk will cover new “solMPMP” tech from @nablabio where we use generative ML to create soluble proxies of valuable multipass membrane protein drug targets, and use these proxies to facilitate design of new biologics.

Tweet Image 1

Nabla Bio Reposted

Excited to share @nablabio is partnering with 3 of the world’s largest pharma cos to use integrated AI and wet-lab tech to design antibodies against challenging disease targets. Thrilled to also add @radicalvcfund who led our $26M Series A to the family! bit.ly/4dDk4lP


Today we announce the close of a $26M Series A financing, led by @radicalvcfund with participation from all existing investors, and pharmaceutical collaborations with @AstraZeneca, @bmsnews, and @TakedaPharma Thanks to @endpts for breaking our news. endpts.com/exclusive-astr…


Nabla Bio Reposted

Introducing the Spinout Playbook, a free guide to spinning a startup out of academia. fiftyyears.com/spinout Why is this needed? The process of “spinning out” science from universities is broken 👇🧵


Nabla Bio Reposted

Beep boop 🤖 Very excited to share two new computational roles at Nabla! - 3D / Structural ML Scientist - Software Engineer bit.ly/3skpwmI


Nabla Bio Reposted

“We’re in the first five years of developability being recognized as one of the main reasons antibodies are failing in the clinic.” @nablabio is using #AI to design antibodies with therapeutic potential AND optimal biophysical properties. techcrunch.com/2021/12/07/nab… #BuiltOnBenchling


Loading...

Something went wrong.


Something went wrong.